Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Bruce L. Roberts"'
Autor:
Satoru Morita, Takeshi Tanoue, Kozue Takeshita, Yutaka Kawakami, Ashwin N. Skelly, Hera Vlamakis, Jason M. Norman, Kenya Honda, Makoto Suematsu, Bernat Olle, Vanni Bucci, Tomonori Yaguchi, Takashi Inoue, Koji Atarashi, Masahira Hattori, Iori Motoo, Keiko Yasuma-Mitobe, Daniel Mucida, Seiko Narushima, Bruce L. Roberts, Dieter Riethmacher, Ramnik J. Xavier, Atsushi Shiota, Damian R. Plichta, Yuki Sugiura, Wataru Suda, Kayoko Sugita, Tsuneyasu Kaisho
Publikováno v:
Nature. 565:600-605
There is a growing appreciation for the importance of the gut microbiota as a therapeutic target in various diseases. However, there are only a handful of known commensal strains that can potentially be used to manipulate host physiological functions
Autor:
Sambasiva P Rao, Jose Sancho, Juanita Campos-Rivera, Paula M Boutin, Peter B Severy, Timothy Weeden, Srinivas Shankara, Bruce L Roberts, Johanne M Kaplan
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e39416 (2012)
Alemtuzumab is a monoclonal antibody that targets cell surface CD52 and is effective in depleting lymphocytes by cytolytic effects in vivo. Although the cytolytic effects of alemtuzumab are dependent on the density of CD52 antigen on cells, there is
Externí odkaz:
https://doaj.org/article/5deecdc8b16d435480f9c85d5a9e76d0
Autor:
Amit Reddy, Arthur E. Frankel, Bruce L. Roberts, Maureen Hayes, Andrew Y. Koh, John Lightcap, Sachin Kumar Deshmukh, Brooks D. Rabideau, Steven McClellan, T. Grant Glover, Seema Singh
Publikováno v:
Integrative Cancer Therapies, Vol 18 (2019)
Integrative Cancer Therapies
Integrative Cancer Therapies
The past decade has seen tremendous advances in both our understanding of cancer immunosuppressive microenvironments and colonic bacteria facilitated by immune checkpoint inhibitor antibodies and next generation sequencing, respectively. Because an i
Autor:
Jason M. Norman, Bruce L. Roberts, Judy Wang, Diwakar Davar, Michael Cecchini, Zev A. Wainberg, Bernat Olle, Anita Ahmed Turk, Dmitri Bobilev, Rose L. Szabady, Martin Gutierrez
Publikováno v:
Cancer Research. 80:CT246-CT246
Background: Gut microbiome composition affects response to PD-1 blockade; and recent proof of concept studies suggest that gut microbiome manipulation is effective in reversing resistance to PD-1 blockade. VE800 is an oral live biotherapeutic consist
Autor:
Melissa Dsouza, Jessica S. Schneider, Bruce L. Roberts, Dmitri Bobilev, Brian Klein, Vanni Bucci, Jason M. Norman, Bernat Olle, Shilpa P. Reddy
Publikováno v:
Gastroenterology. 158:S-15
Autor:
Steve McClellan, Kenya Honda, Johnny Lightcap, Amit Reddy, Andrew Y. Koh, Arthur E. Frankel, Rose L. Szabady, Bruce L. Roberts, Sachin Kumar Deshmukh
Publikováno v:
Journal of Clinical Oncology. 37:e14195-e14195
e14195 Background: Immune checkpoint inhibitor therapy, ICT, achieves remissions in melanoma patients but factors modulating response are not well defined. Our group (Frankel et al. Neoplasia 2017) and others have identified specific gut microbiota a
Autor:
Lou Vaickus, Dmitri Bobilev, Paolo DePetrillo, Jason M. Norman, Shilpa Reddy, Brian Klein, Bernat Olle, Bruce L. Roberts
Publikováno v:
Gastroenterology. 156:S-899
Autor:
Johanne Kaplan, William M. Siders, Evis Havari, Tri-Hung Nguyen, Michael J. Turner, Srinivas Shankara, Bruce L. Roberts, Juanita Campos-Rivera
Publikováno v:
Immunology. 141:123-131
Alemtuzumab is a humanized monoclonal antibody specific for the CD52 protein present at high levels on the surface of B and T lymphocytes. In clinical trials, alemtuzumab has shown a clinical benefit superior to that of interferon-β in relapsing-rem
Autor:
William M. Siders, Srinivas Shankara, Jacqueline Shields, Paula Boutin, Carrie Garron, Johanne Kaplan, Yanping Hu, William Weber, Bruce L. Roberts
Publikováno v:
Leukemia & Lymphoma. 51:1293-1304
Alemtuzumab is a recombinant humanized IgG1 monoclonal antibody directed against CD52, an antigen expressed on the surface of normal and malignant B and T lymphocytes. Alemtuzumab is approved for the treatment of B-cell chronic lymphocytic leukemia (
Autor:
William Weber, Nakayuki Honma, Paula Boutin, Cecile Rouleau, Srinivas Shankara, Rebecca G. Bagley, Beverly A. Teicher, Shiro Kataoka, Bruce L. Roberts, Isao Ishida
Publikováno v:
Microvascular Research. 76:180-188
The formation of functional, mature blood vessels depends on the interaction between endothelial cells and pericytes. Commonality exists in the processes involved in vasculature development between tissues whether healthy or diseased. Endosialin/TEM